BY OUR PLATFORMS
BY THERAPEUTIC AREA
Carles Cornet - 16 November 2022
Combining a zebrafish-based high throughput platform with artificial intelligence for human developmental toxicity assessment.
Javier Terriente - 15 September 2022
AI can address many challenges and limitations in traditional R&D and offer value in drug discovery in multiple ways.
Carles Cornet - 11 May 2022
Why zebrafish can pave the way for investigating epilepsy’s etiology and screening new anti-seizure drugs
Sylvia Dyballa - 12 May 2021
In ZeClinics we bet on emerging technologies to scale our solutions.
Sergio Jarque - 10 March 2021
From challenge to knowledge: the outstanding performance of zebrafish in predicting toxicity.
Vincenzo Di Donato - 13 January 2021
ZeClinics laboratory R&D efforts are mainly divided in the development of three research platforms including a number of research areas.